Clinicopathological and Preclinical Patient-Derived Model Studies Define High Expression of NRN1 as a Diagnostic and Therapeutic Target for Clear Cell Renal Cell Carcinoma

Clinicopathological and Preclinical Patient-Derived Model Studies Define High Expression of NRN1 as a Diagnostic and Therapeutic Target for Clear Cell Renal Cell Carcinoma

BackgroundAcquired therapeutic resistance and metastasis/recurrence remain significant challenge in advance renal cell carcinoma (RCC), thus the establishment of patient-derived cancer models may provide a clue to assess the problem. We recently characterized that neuritogenesis-related protein neur...

Full description

Bibliographic Details
Main Authors:	Shuhei Kamada, Kazuhiro Ikeda, Takashi Suzuki, Wataru Sato, Sachi Kitayama, Satoru Kawakami, Tomohiko Ichikawa, Kuniko Horie, Satoshi Inoue
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Oncology
Subjects:	renal cell carcinoma patient-derived cancer cell (PDC) patient-derived xenograft cancer stem-like cell cancer stemness spheroid
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.758503/full

Similar Items

Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
by: Takeshi Namekawa, et al.
Published: (2019-01-01)

Investigation the Ability to Produce Induced Pluripotent Cells from Human Pancreatic Cancer Xenografts
by: Reyhaneh Khoshchehreh, et al.
Published: (2019-08-01)

Novel organoid model in drug screening: Past, present, and future
by: Xialin Nie, et al.
Published: (2021-06-01)

Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy
by: Takehito Yamamoto, et al.
Published: (2020-07-01)

Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells
by: Gen Nishikawa, et al.
Published: (2022-10-01)

Patient-Derived In Vitro Models of Ovarian Cancer: Powerful Tools to Explore the Biology of the Disease and Develop Personalized Treatments
by: Chiara Battistini, et al.
Published: (2023-01-01)

Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts
by: Takeshi Kuwata, et al.
Published: (2019-06-01)

Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models
by: Rachel A. Sabol, et al.
Published: (2019-05-01)

Targeting Endometrial Cancer Stem Cell Activity with Metformin Is Inhibited by Patient-Derived Adipocyte-Secreted Factors
by: Sarah J. Kitson, et al.
Published: (2019-05-01)

Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma
by: Sarah Meneceur, et al.
Published: (2020-04-01)

Patient-Derived Glioma Models: From Patients to Dish to Animals
by: Cintia Carla da Hora, et al.
Published: (2019-09-01)

Preclinical evaluation of cancer immune therapy using patient‐derived tumor antigen‐specific T cells in a novel xenograft platform
by: Gautam N Shenoy, et al.
Published: (2021-01-01)

The generation of glioma organoids and the comparison of two culture methods
by: Yang Zhang, et al.
Published: (2024-02-01)

O-Acetyl-GD2 as a Therapeutic Target for Breast Cancer Stem Cells
by: Jing-Yan Cheng, et al.
Published: (2022-01-01)

Induction of Lysosome Membrane Permeabilization as a Therapeutic Strategy to Target Pancreatic Cancer Stem Cells
by: Timothy P. Cash, et al.
Published: (2020-07-01)

Endometrial Cancer Patient-Derived Xenograft Models: A Systematic Review
by: Tomohito Tanaka, et al.
Published: (2022-05-01)

Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer
by: Han Na Kang, et al.
Published: (2020-04-01)

Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model
by: Kulthida Vaeteewoottacharn, et al.
Published: (2019-05-01)

Establishment of lung cancer patient-derived xenograft models and primary cell lines for lung cancer study
by: Yanan Jiang, et al.
Published: (2018-05-01)

Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer
by: Willy Antoni Abreu de Oliveira, et al.
Published: (2021-07-01)

Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis
by: Arturo B. Ramirez, et al.
Published: (2019-03-01)

Production of engineered cartilage from mesenchymal stem cell spheroids
by: Ha Thi-Ngan Le, et al.
Published: (2020-10-01)

Cancer Stem Cell-Exosomes, Unexposed Player in Tumorigenicity
by: Batla S. Al-Sowayan, et al.
Published: (2020-03-01)

Mesenchymal Stem Cells As Guideposts for Nanoparticle-Mediated Targeted Drug Delivery in Ovarian Cancer
by: Buddhadev Layek, et al.
Published: (2020-04-01)

Effect of <i>ALDH1A1</i> Gene Knockout on Drug Resistance in Paclitaxel and Topotecan Resistant Human Ovarian Cancer Cell Lines in 2D and 3D Model
by: Marta Nowacka, et al.
Published: (2022-03-01)

Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models
by: Ergang Wang, et al.
Published: (2022-12-01)

Multicellular Modelling of Difficult-to-Treat Gastrointestinal Cancers: Current Possibilities and Challenges
by: Sarah K. Hakuno, et al.
Published: (2022-03-01)

Current Status of Patient-Derived Ovarian Cancer Models
by: Yoshiaki Maru, et al.
Published: (2019-05-01)

The organoid: A research model for ovarian cancer
by: Yu-Hsun Chang, et al.
Published: (2022-01-01)

New generation breast cancer cell lines developed from patient-derived xenografts
by: Jessica Finlay-Schultz, et al.
Published: (2020-06-01)

Patient-Derived Xenograft Models in Urological Malignancies: Urothelial Cell Carcinoma and Renal Cell Carcinoma
by: Andrew T. Tracey, et al.
Published: (2020-02-01)

Impact of media compositions and culture systems on the immunophenotypes of patient-derived breast cancer cells
by: Seungyeon Ryu, et al.
Published: (2023-09-01)

PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells
by: Xinru Wei, et al.
Published: (2017-03-01)

Changes in Stem Cell Regulation and Epithelial Organisation during Carcinogenesis and Disease Progression in Gynaecological Malignancies
by: Paula Cunnea, et al.
Published: (2021-07-01)

Fabrication of a Three-Dimensional Spheroid Culture System for Oral Squamous Cell Carcinomas Using a Microfabricated Device
by: Reiko Ikeda-Motonakano, et al.
Published: (2023-10-01)

Long Non-coding RNAs Involved in Metabolic Alterations in Breast and Prostate Cancers
by: Shuhei Kamada, et al.
Published: (2020-10-01)

Patient-Derived Xenograft vs. Organoids: A Preliminary Analysis of Cancer Research Output, Funding and Human Health Impact in 2014–2019
by: Lindsay J. Marshall, et al.
Published: (2020-10-01)

The Epithelial–Mesenchymal Transcription Factor <i>SNAI1</i> Represses Transcription of the Tumor Suppressor miRNA <i>let-7</i> in Cancer
by: Hanmin Wang, et al.
Published: (2021-03-01)

Preclinical models as patients’ avatars for precision medicine in colorectal cancer: past and future challenges
by: Erika Durinikova, et al.
Published: (2021-06-01)

An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer
by: Xiang Ling, et al.
Published: (2018-10-01)